Different strategy of salvage esophagectomy between residual and recurrent esophageal cancer after definitive chemoradiotherapy

摘要

BackgroundClinical outcomes appear to differ between patients with residual or recurrent esophageal cancer after definitive chemoradiotherapy. We aimed to identify the patients most likely to benefit from this high-risk surgery, divided by the patients whose cancer was residual and recurrent groups, respectively.